Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 05/23/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 05/23/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 05/23/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 05/09/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 05/03/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 05/02/12 | 8-K | Current report filing |
|
3 | |
| 04/30/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/20/12 | 8-K | Current report filing |
|
18 | |
| 04/19/12 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
8 | |
| 04/18/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
